NFKBIA and lung cancer: Adenovirus-mediated delivery of IKKβ (Ad.IKKβKA) [17,18] or IkBα (Ad.IkBαSR) [40,43] dominant negative mutants have previously been demonstrated to sensitize lung cancer cells to TNF death ligand.